New breast cancer screening guidelines call for earlier and more-intensive screening for high-risk women

byElsevierCredit: Unsplash/CC0 Public DomainNew American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk

Updated on: January 12,2024

New breast cancer screening guidelines call for earlier and more-intensive screening for high-risk women

byElsevierCredit: Unsplash/CC0 Public DomainNew American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk

Updated on:January 12,2024

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on: January 30,2024

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on:January 30,2024

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on: May 11,2024

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on:May 11,2024

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr

Updated on: February 19,2024

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr

Updated on:February 19,2024

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part

Updated on: June 15,2024

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part

Updated on:June 15,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on: May 07,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on:May 07,2024

Stopping the spread: Targeting tumor metastasis

by Tokyo Medical and Dental UniversityTakahashi et al. show that TGF-β generates a population of cancer cells under cell cycle arrest in G1 phase with high motility by inducing unique Slug/HMGA2-indep

Updated on: January 22,2024

Stopping the spread: Targeting tumor metastasis

by Tokyo Medical and Dental UniversityTakahashi et al. show that TGF-β generates a population of cancer cells under cell cycle arrest in G1 phase with high motility by inducing unique Slug/HMGA2-indep

Updated on:January 22,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on: March 20,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on:March 20,2024

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix

Updated on: January 12,2024

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix

Updated on:January 12,2024

Physicians debate CRC guidelines, available screening options for younger patients

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainIn a newAnnals of Internal Medicine"Beyond the Guidelines" feature, a primary care physician and a gastroen

Updated on: January 30,2024

Physicians debate CRC guidelines, available screening options for younger patients

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainIn a newAnnals of Internal Medicine"Beyond the Guidelines" feature, a primary care physician and a gastroen

Updated on:January 30,2024

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442

Updated on: January 23,2024

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442

Updated on:January 23,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on: June 04,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on:June 04,2024